Extended efficacy and safety from the phase III
MANEUVER trial of pimicotinib in patients with
tenosynovial giant cell tumour (TGCT)
2690MO
ARTEMIS-002: A phase II study of HS-20093 in patients
with relapsed or refractory sarcomas
2684O
Legubicin versus doxorubicin (DOX) in patients (pts) with
advanced soft tissue sarcoma (STS): Results of randomized,
phase II/III study
LBA97
Twenty year survival of advanced gastrointestinal stromal
tumours treated with imatinib: Exploratory long-term
follow-up of the BFR14 trial
2691MO
CONgRAtS: A randomized phase II study of
nivolumab±relatlimab in patients with TLS-positive
soft-tissue sarcomas
2687MO
Efficacy and safety of metronomic cyclophosphamide (MC)
VS doxorubicin (DOXO) as first-line treatment in older
patients (PTS) with advanced soft tissue sarcomas (STS): The
METROPHOLYS trial
2692MO
ESMO 2025
SARCOMA Y ENFERMEDADES RARAS
ESMO 2025
Tu canal independiente de oncología en español
Top resúmenes y presentaciones
Regístrate aquí para recibir más contenidos
Registrarse